Scrambler Therapy in Chronic Pancreatitis

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Dec 1, 2026 to Dec 1, 2027
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 4 of 11 entries
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators will enroll adults with chronic pancreatitis who have persistent abdominal pain not relieved by standard treatments. This study will test the feasibility and effectiveness of Scrambler Therapy, a non-invasive FDA-cleared device that delivers "non-pain" electrical signals through the skin to retrain the brain's pain perception. Participants will undergo 5-10 treatment sessions and be followed for 3 months with standardized pain scores and quality-of-life assessments. The goal is to generate pilot data to support larger studies of Scrambler Therapy as a novel option for pancreatic pain.
Trial Details
NCT Number NCT07174609
Lead Sponsor Johns Hopkins University
Collaborators: The National Pancreas Foundation
Conditions
(from sponsor)		 Chronic Pain, Pancreatitis, Chronic Pancreatitis
Related terms Abdominal Pain, Chronic Pain, Pancreatitis, Pancreatitis, Chronic
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov